- Home
- CGON vs ADX Comparison
CGON vs ADX Comparison
Compare CGON & ADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGON
- ADX
- Stock Information
- Founded
- CGON 2010
- ADX 1840
- Country
- CGON United States
- ADX United States
- Employees
- CGON 61
- ADX N/A
- Industry
- CGON
- ADX Investment Managers
- Sector
- CGON
- ADX Finance
- Exchange
- CGON NYSE
- ADX Nasdaq
- Market Cap
- CGON 2.2B
- ADX 2.4B
- IPO Year
- CGON 2024
- ADX N/A
- Fundamental
- Price
- CGON $32.84
- ADX $22.01
- Analyst Decision
- CGON Strong Buy
- ADX
- Analyst Count
- CGON 8
- ADX 0
- Target Price
- CGON $63.88
- ADX N/A
- AVG Volume (30 Days)
- CGON 396.6K
- ADX 182.4K
- Earning Date
- CGON 11-12-2024
- ADX 01-01-0001
- Dividend Yield
- CGON N/A
- ADX 6.68%
- EPS Growth
- CGON N/A
- ADX N/A
- EPS
- CGON N/A
- ADX N/A
- Revenue
- CGON $684,000.00
- ADX N/A
- Revenue This Year
- CGON $411.76
- ADX N/A
- Revenue Next Year
- CGON $405.27
- ADX N/A
- P/E Ratio
- CGON N/A
- ADX N/A
- Revenue Growth
- CGON 258.12
- ADX N/A
- 52 Week Low
- CGON $25.77
- ADX $14.94
- 52 Week High
- CGON $50.23
- ADX $19.57
- Technical
- Relative Strength Index (RSI)
- CGON 41.08
- ADX 59.62
- Support Level
- CGON $35.12
- ADX $22.22
- Resistance Level
- CGON $40.47
- ADX $22.58
- Average True Range (ATR)
- CGON 1.69
- ADX 0.21
- MACD
- CGON -0.28
- ADX 0.02
- Stochastic Oscillator
- CGON 4.57
- ADX 71.36
About CGON CG ONCOLOGY INC
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
About ADX Adams Diversified Equity Fund Inc.
Adams Diversified Equity Fund Inc is a diversified investment company. It is an internally-managed closed-end fund. The investment objectives of the company are the preservation of capital, the attainment of reasonable income from investments, and an opportunity for capital appreciation. It has a diversified equity portfolio which consists of securities of companies from Energy, Consumer Staples, Information Technology, Financials and other sectors.